Oncolytics reports accelerated enrollment, expects Part A interim REO 033 data by year-end 2026

Oncolytics reported that substantially all REO 033 sites are activated and expects interim Part A data by year-end 2026.Key Highlights:Original SEC Filing: ONCOLYTICS BIOTECH INC [ ONCY ] - 8-K - Sep. 28, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important i…